Lattice Medical is a biomedical start-up that was launched in October 2017
Patented 3D technology developed with CHU Lille-France that allows adipose tissue to naturally regenerate
Designed and made
with 3D printed biomaterials
Adapted to the individual morphology of patients
in a year
Vascular adipose flap tissue inlaid
over the Tissue Engineering Chamber (TEC)
The desired size is reached after just one surgery: breasts are entirely reconstructed by the patient’s tissues, and no foreign bodies are introduced.
Following surgery, serious burns, chronic wounds, and accidents, traumatized soft tissue needs to be repaired.
In collaboration with CHU Lille, Lattice Medical provides product design, R&D services, and various solutions for soft tissue engineering and regeneration. Alongside textile manufacturing partners, we develop textile matrixes (including Calais lace ones) that are obtained through the Leavers method.
Lattice Medical offers sub-licensing R&D contracts to manufacturers and provides pre-clinical proof-of-concept studies.
Thanks to its integrated platform, Lattice Medical is able to offer innovative solutions and the opportunity for biomedical projects to explore new technological landscapes. Lattice Medical is helping manufacturers in the medical procedure industry with their transition towards 3D technology.
Lattice Medical is developing the first ISO 13485 production in clean room with 3D printing for designing personalized implantable resorbable medical devices.
This unique platform is endowed with new 3D printing and extrusion technology that is able to produce prototypes, pre-series and industrial series for R&D trials, pre-clinical and clinical studies at extremely low particular pollution levels.
Want to test specific medical grade polymers for R&D purpose in 3D printing medical area such as tissue engineering, custom medical devices or 3D printed prototypes. Try our filaments for 3D printing.
Many thanks to the 3DMedNet journal for their article on LATTICE MEDICAL in the last issue : “Applications of 3D printing in oncology: breast and soft tissue reconstruction”
“La première bioprothèse à régénération cellulaire pour la reconstruction mammaire a été mise au point par la jeune entreprise lilloise Lattice Medical. Elle vient de boucler un financement de 2,3 millions d’euros pour valider son dispositif médical et mener les essais cliniques nécessaires à l’obtention du marquage CE.”
Source : Les Echos, Lattice Medical réunit 2,3 millions pour ses bioprothèses mammaires
“Lattice Medical, pépite des Hauts-de-France soutenue par la Région, met au point une bioprothèse implantable pour la reconstruction mammaire. Une innovation qui permettrait à des milliers de femmes de retrouver, une fois le cancer du sein vaincu, une vie après la maladie.”
Source : Hauts-de-France, Une nouvelle vie après le cancer du sein : le défi de Lattice Medical
“Seules 15 % des 1,7 millions de femmes touchées chaque année dans le monde par le cancer bénéficient d’une reconstruction mammaire. Pour offrir une alternative aux possibilités thérapeutiques classiques particulièrement coûteuses et lourdes en chirurgie, une jeune pousse tricolore du nom Lattice Medical a imaginé une prothèse imprimée en 3D 100 % bio-résorbable et personnalisable.”
LATTICE MEDICAL fait partie des 12 lauréats sélectionnés par le SNITEM pour pitcher et avoir son stand lors des journées Start-UP du Dispositif Médical organisées le 14 mai à la cité des sciences de Paris.
Source : https://www.snitem.fr/startup2019
The whole LATTICE MEDICAL team has moved in our new offices in the Eurasanté Park in the heart of Lille Hospitals (CHU Lille). We are glad to have 300 m² space and a dedicated space of 70 m² for our 3D printing platform. Few months of works and we will be able to inaugurate the new offices.
The whole team LATTICE MEDICAL wishes you all the best for the year 2019. LATTICE MEDICAL ends 2018 with a lot of great things:
2019 will be for us a 200% year with the same desire to bring a new solution for all patients wishing to obtain a natural breast reconstruction.
Happy New Year !
LATTICE MEDICAL is proud to announce the closing of our first seed round. It will help us accelerate the pre-clinical phase of the project. We would like to thank the commitment of the investment funds and their investors in our project: Finovam, FIRA Nord Est, NORD FRANCE AMORCAGE and WiSEED. We also thank the support of Bpifrance through various funding tools and competitions that makes it possible to complete a first round of funding for a total of 2.3 million euros. We are still on the way to bring a real solution and a revolution in breast reconstruction.
LATTICE MEDICAL exposed at the MEDFIT exhibition, special in innovative medical devices, on 26 and 27 June in Strasbourg. It was the first trade show for the company displaying its products. We had the opportunity to present our product in front of a jury of professionals (J & J, MEDTRONIC, URGO) for which he was very well received and encouraged. We had more than 150 visits to our booth over the two days and made many contacts.